News & Events
News & Events
Institut Pasteur Korea (IPK) and the Korea Innovation Foundation Discuss Strategies to Support R&D for Domestic Pharmaceutical and Biotechnology Companies
2024-08-01
Institut Pasteur Korea (IPK) and the Korea Innovation Foundation Discuss Strategies to Support R&D for
Domestic Pharmaceutical and Biotechnology Companies
Domestic Pharmaceutical and Biotechnology Companies
.jpg)
Institut Pasteur Korea (IPK) has engaged in discussions with the Korea Innovation Foundation on strategies to support research and development (R&D) for domestic pharmaceutical and biotechnology companies and agreed on mutual cooperation.
On the 1st of the month, Sung Key Jang, CEO of Institut Pasteur Korea, met with Hee Kwon Jung, Chairman of the Korea Innovation Foundation, to confirm the potential for complementary cooperation between the two organizations to utilize infectious disease research infrastructure and support overseas expansion for domestic companies.
.jpg)
Specifically, they agreed to prioritize collaboration to enable tenant companies in the pharmaceutical and biotechnology sectors within the research and development zones to utilize infrastructure and resources for infectious disease treatment, vaccine, and diagnostic research, such as IPK's Biosafety Level 3 (BSL-3) and Animal Biosafety Level 3 (ABSL-3) laboratories, as well as its Biobank.
Additionally, they will work together to facilitate overseas expansion and commercialization through IPK's global network, including the Pasteur Network.